Actinium Pharmaceuticals, Inc. (ATNM)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Actinium Pharmaceuticals, Inc. (ATNM)
Go deeper and ask any question about ATNM
Company Performance
Current Price
as of Sep 13, 2024$1.86
P/E Ratio
N/A
Market Cap
$57.95M
Description
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel targeted therapies. It also develops and markets medicines for relapsed or refractory cancer patients. The company was founded in 2000 and is headquartered in New York, NY.
Metrics
Overview
- HQNew York, NY
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerATNM
- Price$1.86-5.10%
Trading Information
- Market Cap$57.95M
- Float96.54%
- Average Daily Volume (1m)456,563
- Average Daily Volume (3m)835,432
- EPS-$1.52
Company
- Revenue$0.08M
- Rev Growth (1yr)N/A
- Net Income-$11.35M
- Gross MarginN/A
- EBITDA MarginN/A
- EBITDA-$12.23M
- EV$138.58M
- EV/Revenue1,710.80
- P/EN/A
- P/S691.26
Documents
SEC Filings
Factset Street Account
Factset